APRE Latest Headlines

Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA), Warby Parker (WRBY) and Aprea Therapeutics (APRE)

at www.tipranks.com (Thu, 13-Aug 7:50 AM)

Aprea Therapeutics advances APR-1051 oncology pipeline progress

at www.tipranks.com (Wed, 12-Aug 8:58 AM)

Aprea Therapeutics GAAP EPS of -$0.07 beats by $0.16

at seekingalpha.com (Wed, 12-Aug 8:32 AM)

Aprea Therapeutics: Buy Rating Reiterated as APR-1051 Clinical Momentum Builds; $1.20 Price Target Maintained

at www.tipranks.com (Mon, 10-Aug 12:25 PM)